BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31034503)

  • 1. Associations among circulating levels of follistatin-like 1, clinical parameters, and cardiovascular events in patients undergoing elective percutaneous coronary intervention with drug-eluting stents.
    Aikawa T; Shimada K; Miyauchi K; Miyazaki T; Sai E; Ouchi S; Kadoguchi T; Kunimoto M; Joki Y; Dohi T; Okazaki S; Isoda K; Ohashi K; Murohara T; Ouchi N; Daida H
    PLoS One; 2019; 14(4):e0216297. PubMed ID: 31034503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    Oishi H; Okumura T; Ohashi K; Kimura Y; Kazama S; Shibata N; Arao Y; Kato H; Kuwayama T; Yamaguchi S; Tatsumi M; Kondo T; Hiraiwa H; Morimoto R; Takefuji M; Ouchi N; Murohara T
    J Cardiol; 2021 Dec; 78(6):524-532. PubMed ID: 34334268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Plasma Follistatin-like Protein 1 Levels and the Presence and Severity of Coronary Artery Disease.
    Yamazaki Y; Kishimoto Y; Saita E; Aoyama M; Ikegami Y; Ohmori R; Tanimoto K; Kondo K; Momiyama Y
    Int Heart J; 2021; 62(6):1207-1212. PubMed ID: 34853217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes: a comparable and additive study.
    Moon AR; Choi DH; Jahng SY; Kim BB; Seo HJ; Kim SH; Ryu SW; Song H; Kim TH
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):70-6. PubMed ID: 26340462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
    Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
    Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
    Cho KI; Ann SH; Singh GB; Her AY; Shin ES
    PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
    Moon J; Suh J; Oh PC; Lee K; Park HW; Jang HJ; Kim TH; Park SD; Kwon SW; Kang WC
    Am J Cardiol; 2016 Jul; 118(2):177-82. PubMed ID: 27236252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
    Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
    Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
    Jeger R; Jaguszewski M; Nallamothu BN; Lüscher TF; Urban P; Pedrazzini GB; Erne P; Radovanovic D;
    Int J Cardiol; 2014 Mar; 172(1):76-81. PubMed ID: 24461983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.